Trials / Not Yet Recruiting
Not Yet RecruitingNCT05786287
Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
Long-term Safety of Umbilical Cord-Mesenchymal Stem Cell (UC-MSC) Transplantation in Patients With Retinitis Pigmentosa
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (estimated)
- Sponsor
- PT. Prodia Stem Cell Indonesia · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study will perform to follow-up UC-MSCs and CM transplantation. 18 patients will be called back to be examined after 5 years of UC-MSC and/or CM transplantation.
Detailed description
The study will be performed on 18 patients who received UC-MSC and CM transplantation in 2018. The study is included as retrospective cohort since the transplantation happened 5 years ago. Patients will do a visual field test, visual acuity test, electroretinography, funduscopy, and Optical Coherence Tomography examination. The observation results will be written in the observation table and analyzed by a statistic.The study will be performed at Rumah Sakit Jakarta Eye Center and Rumah Sakit Umum Pusat Dr. Sardjito Yogyakarta.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Conditioned Medium (CM) | Conditioned Medium (CM) injected by peribulbar |
| BIOLOGICAL | Umbilical Cord Mesenchymal Stem Cell (UC-MSC) | Umbilical Cord Mesenchymal Stem Cell (UC-MSC) injected by peribulbar |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2027-07-01
- Completion
- 2027-09-01
- First posted
- 2023-03-27
- Last updated
- 2026-02-25
Locations
2 sites across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT05786287. Inclusion in this directory is not an endorsement.